Nasaleze TM预防和治疗变应性鼻炎的疗效和安全性综述

P. Bouic
{"title":"Nasaleze TM预防和治疗变应性鼻炎的疗效和安全性综述","authors":"P. Bouic","doi":"10.2174/1874838400801010001","DOIUrl":null,"url":null,"abstract":"Nasaleze TM is an inert cellulose powder which has been on sale in the UK since 1994 and is used as a remedy for hay fever. It is applied to the nasal passage where it forms a gelatinous coating, thereby trapping aero-allergens and preventing the initial allergic response. Some limited clinical studies have been conducted in predominantly adults but also in children: outcome measures included the reporting of symptoms by volunteers (sneezing, itching, blocked nose, etc) using questionnaires; prevention of symptoms when challenged to aerosolized allergens; concomitant use of rescue medication and the measurement of inspiratory air flow across the mucosa as well as the release of ECP in nasal wash- ings. The product has been reported to be safe and well tolerated by all volunteers and warrant further investigation in larger studies.","PeriodicalId":22835,"journal":{"name":"The Open Allergy Journal","volume":"49 1","pages":"1-4"},"PeriodicalIF":0.0000,"publicationDate":"2008-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"A review of the efficacy and safety of Nasaleze TM in the prevention and management of allergic rhinitis\",\"authors\":\"P. Bouic\",\"doi\":\"10.2174/1874838400801010001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Nasaleze TM is an inert cellulose powder which has been on sale in the UK since 1994 and is used as a remedy for hay fever. It is applied to the nasal passage where it forms a gelatinous coating, thereby trapping aero-allergens and preventing the initial allergic response. Some limited clinical studies have been conducted in predominantly adults but also in children: outcome measures included the reporting of symptoms by volunteers (sneezing, itching, blocked nose, etc) using questionnaires; prevention of symptoms when challenged to aerosolized allergens; concomitant use of rescue medication and the measurement of inspiratory air flow across the mucosa as well as the release of ECP in nasal wash- ings. The product has been reported to be safe and well tolerated by all volunteers and warrant further investigation in larger studies.\",\"PeriodicalId\":22835,\"journal\":{\"name\":\"The Open Allergy Journal\",\"volume\":\"49 1\",\"pages\":\"1-4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Open Allergy Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1874838400801010001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Allergy Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874838400801010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

摘要

Nasaleze TM是一种惰性纤维素粉末,自1994年以来一直在英国销售,用于治疗花粉热。它被应用于鼻腔通道,在那里形成凝胶状涂层,从而捕获空气过敏原,防止最初的过敏反应。一些有限的临床研究主要在成人中进行,但也在儿童中进行:结果测量包括通过问卷调查报告志愿者的症状(打喷嚏、瘙痒、鼻塞等);预防雾化过敏原引起的症状;同时使用抢救药物和测量粘膜吸入气流以及鼻洗液中ECP的释放。据报道,该产品在所有志愿者中都是安全且耐受性良好的,值得在更大规模的研究中进一步调查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A review of the efficacy and safety of Nasaleze TM in the prevention and management of allergic rhinitis
Nasaleze TM is an inert cellulose powder which has been on sale in the UK since 1994 and is used as a remedy for hay fever. It is applied to the nasal passage where it forms a gelatinous coating, thereby trapping aero-allergens and preventing the initial allergic response. Some limited clinical studies have been conducted in predominantly adults but also in children: outcome measures included the reporting of symptoms by volunteers (sneezing, itching, blocked nose, etc) using questionnaires; prevention of symptoms when challenged to aerosolized allergens; concomitant use of rescue medication and the measurement of inspiratory air flow across the mucosa as well as the release of ECP in nasal wash- ings. The product has been reported to be safe and well tolerated by all volunteers and warrant further investigation in larger studies.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信